Pia Suvitie

ORCID: 0000-0002-8729-4448 · 22 papers in corpus
other 2025
BMC women's health ·doi:10.1186/s12905-025-03699-y

BACKGROUND: Sacral neuromodulation (SNM) is an established therapy in urology and gastroenterological surgery for treatment of overactive bladder symptoms, urge urinary incontinence or fecal incontinence. SNM has also been used with good re…

review 2025
Current opinion in obstetrics & gynecology ·doi:10.1097/gco.0000000000001027

PURPOSE OF REVIEW: Endometriosis is a chronic inflammatory condition that significantly affects women's quality of life and fertility. Despite advancements in treatment, many areas of uncertainty persist in clinical management. This review …

observational 2025
·doi:10.1177/22840265251363707

Introduction: When peritoneal endometriosis is clinically suspected, diagnostic and therapeutic laparoscopy may be offered after failed or unsuitable medical therapy. Our objective was to determine how often endometriosis is verified in the…

review 2024
Reproductive BioMedicine Online ·doi:10.1016/j.rbmo.2024.104704

With a growing number of women in developed countries having children later in life, it is time to rethink women's reproductive health. This trend of 'delayed parenthood' reflects a complex interplay of labour market rules, personal choices…

observational 2024
·doi:10.21203/rs.3.rs-4088264/v1

Abstract Background Sacral neuromodulation (SNM) is an established therapy in urology and gastroenterological surgery for treatment of overactive bladder symptoms, urge urinary incontinence or fecal incontinence. SNM has also been used wi…

observational 2024
·doi:10.21203/rs.3.rs-4177916/v1

Abstract Background: When peritoneal endometriosis is clinically suspected, empirical medical therapy should be the first-line treatment. Diagnostic and therapeutic laparoscopy may be offered after failed or unsuitable medical therapy in wo…

nonrandomized-trial 2023
Acta obstetricia et gynecologica Scandinavica ·doi:10.1111/aogs.14690

INTRODUCTION: Chronic pelvic pain (CPP) affects over one fifth of women worldwide, and endometriosis is one of the most common causes. In the present study, we examined whether sacral neuromodulation (SNM) is effective in the treatment of r…

other 2020
Scientific data ·doi:10.1038/s41597-020-00623-x

Endometriosis is a common inflammatory estrogen-dependent gynecological disorder, associated with pelvic pain and reduced fertility in women. Several aspects of this disorder and its cellular and molecular etiology remain unresolved. We hav…

2020
·doi:10.6084/m9.figshare.12195975

Endometriosis is a common inflammatory estrogen-dependent gynecological disorder, associated with pelvic pain and reduced fertility in women. Several aspects of this disorder and its cellular and molecular etiology remain unresolved. We hav…

2019
·doi:10.1016/j.jval.2019.09.1200
review 2018
Duodecim; laaketieteellinen aikakauskirja

Dysmenorrhea affects quality of life, but is often inadequately treated in teenagers. The mainstay of treatment is NSAID, which must be started pre-emptively and in adequate dose. If NSAID provides insufficient pain relief, or when contrace…

2018
·doi:10.13140/rg.2.2.22700.72321

Endometriosis is a common chronic disease, affecting women of reproductive age. Typical symptoms include severe menstrual pain, other pelvic pain symptoms as well as infertility. Adolescent onset of symptoms is common, and the delay between…

other 2018
Human Reproduction ·doi:10.1093/humrep/dey026

STUDY QUESTION: What is the role of SFRP2 in endometriosis? SUMMARY ANSWER: SFRP2 acts as a canonical WNT/CTNNB1 signaling agonist in endometriosis, regulating endometriosis lesion growth and indicating endometriosis lesion borders togethe…

nonrandomized-trial 2017
Journal of Pediatric and Adolescent Gynecology ·doi:10.1016/j.jpag.2017.01.014

STUDY OBJECTIVE: To study the safety and efficacy of dienogest 2 mg in adolescents with suspected endometriosis. DESIGN: A 52-week, open-label, single-arm study. SETTING: In 21 study centers, in 6 European countries. PARTICIPANTS: Adoles…

case-report 2017
Case reports in neurological medicine ·doi:10.1155/2017/2197831

Excision of all endometriotic lesions is the method of choice in the treatment of severe endometriosis resistant to medical therapy. The infiltrating nature of the disease as well as extensive surgery may, however, cause chronic pain that c…

review 2016
Duodecim; laaketieteellinen aikakauskirja

In adenomyosis, endometrial glandular and stromal cells grow inside the myometrium, and form localized or diffusely expanding islets. Smooth muscle cells of the uterus surrounding the adenomyosis colonies become hypertrophic, which may lead…

observational 2014
The Journal of clinical endocrinology and metabolism ·doi:10.1210/jc.2014-1913

CONTEXT: Aberrant sex steroid signaling is suggested to promote endometriosis growth by several mechanisms, and the tissue concentrations of sex steroids are key determinants of the hormone action. However, their concentrations are only sup…

other 2014
Journal of proteome research ·doi:10.1021/pr500384n

New molecular information on potential therapeutic targets or tools for noninvasive diagnosis for endometriosis are important for patient care and treatment. However, surprisingly few efforts have described endometriosis at the protein leve…

observational 2012
Gynecologic Oncology ·doi:10.1016/j.ygyno.2012.03.011

OBJECTIVE: Human epididymal secretory protein E4 (HE4) is a new promising tumor marker developed for the diagnostics and follow up of ovarian cancer. It has yet to become widely accepted in clinical practice, and its biological properties h…

2011
·doi:10.1007/s10397-010-0654-4
2011
·doi:10.1210/endo-meetings.2011.part3.p25.p3-178
other 2009
British journal of cancer ·doi:10.1038/sj.bjc.6605011

Human epididymal secretory protein E4 (HE4, also known as WAP four-disulphide core domain protein 2) is a new promising biomarker for ovarian cancer but its specificity against ovarian endometriotic cysts is only superficially known. We, th…